Attitudes and reported practice for obesity management in Korea after introduction of anti-obesity agents.
This study aimed to evaluate current clinical assessments and management of obesity in the primary care setting in Korea since anti-obesity agents have become available. A questionnaire was sent to eligible primary care physicians selected from a national probability sample in two specialties: family physicians and internists. Of 939 randomly selected physicians, 452 (48.1%) replied. We found that 51.8% of physicians were aware of the definition of obesity, and 33.8% were aware of the definition of abdominal obesity proposed by Asia-Pacific guideline. When evaluating apparently obese patients, 50.0% of respondents measured body mass index (BMI) and 20.4% measured waist circumference. Fewer than 50% of physicians measured blood glucose or lipid profiles, both of which are risk factors for obesity. About 47.3% of physicians prescribed an anti-obesity medication without allowing sufficient time for nonpharmacologic therapy to take effect, and 68.8% of physicians prescribed anti-obesity medications to patients that requested them regardless of obesity status. The majority of respondents did not appropriately evaluate obesity and its risk factors, and were readily susceptible to prescribing anti-obesity medications. Our findings suggest that primary care physicians in Korea need additional education on obesity and its management.
Park
Hye Soon
HS
Department of Family Medicine, University of Ulsan College of Medicine, Seoul, Korea. hyesoon@amc.seoul.kr
Park
Jee-Young
JY
Cho
Hong-Jun
HJ
D000328:Adult; D000367:Age Factors; D019440:Anti-Obesity Agents / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D005194:Family Practice / Q000379:methods*; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007723:Korea; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000378:metabolism / Q000628:therapy*; D010821:Physicians, Family; D010818:Practice Patterns, Physicians'; D012307:Risk Factors; D011795:Surveys and Questionnaires; D015431:Weight Loss
D019440:Anti-Obesity Agents; D001786:Blood Glucose
Prim Care. 2003 Jun;30(2):341-56, vi-vii
14567152
Obes Res. 1995 Nov;3 Suppl 4:419S-423S
8697039
N Engl J Med. 2001 May 3;344(18):1343-50
11333990
Int J Obes Relat Metab Disord. 2002 Oct;26(10):1393-7
12355337
Br J Gen Pract. 1993 Jun;43(371):229-31
8373644
N Engl J Med. 2002 Feb 7;346(6):393-403
11832527
Am J Prev Med. 1987 Nov-Dec;3(6):339-45
3452374
Addict Behav. 1983;8(3):287-95
6666693
Int J Obes Relat Metab Disord. 2002 Aug;26(8):1046-53
12119569
Pharmacoeconomics. 1998 Sep;14(3):269-83
10186466
Am J Prev Med. 1998 May;14(4):374-6
9635089
Prim Care. 2003 Jun;30(2):327-40
14567151
Curr Atheroscler Rep. 2002 Nov;4(6):448-53
12361492
WMJ. 1998 Oct;97(9):20-1, 24-5, 27-37
9810255
Prev Med. 1997 Jul-Aug;26(4):542-9
9245677
Br J Gen Pract. 1991 Apr;41(345):147-50
1817470
Am J Clin Nutr. 1997 Jun;65(6 Suppl):1957S-1962S
9174503
Obes Surg. 2002 Apr;12 Suppl 1:6S-11S
11969107
Fam Pract. 1999 Jun;16(3):250-4
10439978